GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quratis Inc (XKRX:348080) » Definitions » NonCurrent Deferred Liabilities

Quratis (XKRX:348080) NonCurrent Deferred Liabilities : ₩0 Mil (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Quratis NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Quratis's non-current deferred liabilities for the quarter that ended in Mar. 2025 was ₩0 Mil.

Quratis NonCurrent Deferred Liabilities Historical Data

The historical data trend for Quratis's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quratis NonCurrent Deferred Liabilities Chart

Quratis Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial - - - - -

Quratis Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Quratis NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Quratis's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Quratis Business Description

Industry
Traded in Other Exchanges
N/A
Address
306, 13, Teheran-ro 64-gil, Gangnam-gu, Seoul, KOR
Quratis Inc operates as a developer of vaccines and therapies designed to treat tuberculosis. The company develops youth and adults tuberculosis vaccines, messenger ribonucleic acids, and other related immune-related vaccines.

Quratis Headlines

No Headlines